Severe Gestational Hypertension When Antihypertensive Drug Switching Has Not Controlled Blood Pressure

This protocol applies to gestational hypertension — de novo hypertension arising at or after 20 weeks' gestation — in which blood pressure remains in the severe range (systolic BP ≥160 mmHg or diastolic BP ≥110 mmHg) after a switch to an alternative antihypertensive agent has failed to reach the required target.

Clinical Scenario

Gestational hypertension (de novo hypertension at ≥20 weeks' gestation) with severe blood pressure: systolic BP ≥160 mmHg or diastolic BP ≥110 mmHg. Severe hypertension in pregnancy requires urgent management in a monitored setting.

Why This Protocol Is Reached — Previous Treatment Failed

Prior step: switching to an alternative antihypertensive agent from a different drug class

Goal not met: blood pressure was not lowered to systolic BP below 160 mmHg and diastolic BP of 85 mmHg.

Repeated episodes of severe hypertension despite maintenance treatment with multiple antihypertensive classes prompt escalation to this next step.

Next Step — Partial Overview

When blood pressure remains uncontrolled at the severe threshold despite antihypertensive therapy, the management approach shifts to a definitive obstetric intervention.

The full structured protocol specifies the clinical conditions, timing considerations, and complete pathway — access it below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.preghy.2021.09.008

Hypertension arising de novo at ≥ 20 weeks' gestation in the absence of proteinuria or other findings suggestive of pre-eclampsia
Severe hypertension in pregnancy (i.e., sBP ≥ 160 mmHg or dBP ≥ 110 mmHg) requires urgent antihypertensive therapy, in a monitored setting (⊕⊕OO/Strong).
Repeated episodes of severe hypertension despite maintenance treatment with three classes of antihypertensive agents;

View source ↗